SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-21-000010
Filing Date
2021-04-29
Accepted
2021-04-29 07:43:20
Documents
52
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20210331.htm   iXBRL 10-Q 657282
2 EX-31.1 exhibit311q121.htm EX-31.1 10230
3 EX-31.2 exhibit312q121.htm EX-31.2 10220
4 EX-32.1 exhibit321q121.htm EX-32.1 5372
5 EX-32.2 exhibit322q121.htm EX-32.2 5406
  Complete submission text file 0001657312-21-000010.txt   3052256

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20210331.xsd EX-101.SCH 24550
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20210331_cal.xml EX-101.CAL 55271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20210331_def.xml EX-101.DEF 57532
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20210331_lab.xml EX-101.LAB 302731
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20210331_pre.xml EX-101.PRE 179600
11 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20210331_htm.xml XML 394642
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 21867119
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences